On 2025-05-13, Verrica Pharmaceuticals Inc. (VRCA) announced earnings per share of $-0.10 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.14.
The next expected annoucement date for quarterly earnings is 2025-08-13, with an average estimated earnings per share of $-0.10 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-13 | 2025-03-31 | $-0.14 | $-0.10 |
| 2025-03-11 | 2024-12-31 | $-0.25 | $-0.24 |
| 2024-11-04 | 2024-09-30 | $-0.37 | $-0.49 |
| 2024-08-14 | 2024-06-30 | $-0.43 | $-0.37 |
| 2024-05-13 | 2024-03-31 | $-0.54 | $-0.44 |
| 2024-02-29 | 2023-12-31 | $-0.47 | $-0.48 |
| 2023-11-09 | 2023-09-30 | $-0.22 | $-0.32 |
| 2023-08-08 | 2023-06-30 | $-0.22 | $-0.24 |
| 2023-05-09 | 2023-03-31 | $-0.20 | $-0.15 |
| 2023-03-06 | 2022-12-31 | $-0.20 | $-0.14 |
| 2022-11-07 | 2022-09-30 | $-0.11 | $0.03 |
| 2022-08-11 | 2022-06-30 | $-0.36 | $-0.36 |
| 2022-05-09 | 2022-03-31 | $-0.59 | $-0.30 |
| 2022-03-02 | 2021-12-31 | $-0.48 | $-0.35 |
| 2021-11-12 | 2021-09-30 | $-0.54 | $-0.46 |
| 2021-08-10 | 2021-06-30 | $-0.48 | $-0.43 |
| 2021-05-07 | 2021-03-31 | $-0.35 | $-0.04 |
| 2021-03-04 | 2020-12-31 | $-0.43 | $-0.52 |
| 2020-11-09 | 2020-09-30 | $-0.46 | $-0.42 |
| 2020-08-05 | 2020-06-30 | $-0.45 | $-0.38 |
| 2020-05-07 | 2020-03-31 | $-0.39 | $-0.39 |
| 2020-03-13 | 2019-12-31 | $-0.30 | $-0.31 |
| 2019-11-06 | 2019-09-30 | $-0.32 | $-0.24 |
| 2019-08-07 | 2019-06-30 | $-0.34 | $-0.28 |
| 2019-05-07 | 2019-03-31 | $-0.29 | $-0.30 |
| 2019-03-07 | 2018-12-31 | $-0.27 | $-0.30 |
| 2018-11-07 | 2018-09-30 | $-0.25 | $-0.27 |
| 2018-08-07 | 2018-06-30 | $-0.28 | $-1.04 |